Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Dr. Mildred R. Chernofsky is a gynecologic oncologist at Sibley Memorial Hospital and an associate professor in obstetrics and gynecology at George Washington University School of Medicine and the Uniformed Services University of the Health Sciences (USUHS). She practices out of the Sibley Center for Gynecologic Oncology and Advanced Pelvic Surgery. Dr. Chernofsky is affiliated with Sibley Memorial Hospital and George Washington University Hospital. With a focus on gynecology and obstetrics, Dr. Chernofsky has an expertise in advanced laparoscopy, gestational trophoblastic disease and robotic surgery. Dr. Chernofsky earned her medical degree from Pennsylvania State University College of Medicine. She completed a general internship and a residency in obstetrics and gynecology at the National Naval Medical Center of San Diego, as well as a fellowship in gynecologic oncology at the Los Angeles County/University of Southern California Medical Center. Dr. Chernofsky was named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly in 2012 and 2014. She was also named a Top Doctor in the D.C. region by Washingtonian Magazine. Dr. Chernofsky is also a fellow of the American Congress of Obstetricians and Gynecologists. Dr. Chernofsky has clinical interests in uterine, ovarian, cervical and vulvar cancers, as well as genital dysplasia. She has contributed to numerous clinical trials in her position as a principal investigator for Gynecologic Oncology Group (GOG), as well as various publications and presentations. Dr. Chernofsky also participates in patient educational forums both locally and those sponsored by the Foundation for Women’s Cancer. Dr. Chernofsky is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Endometrial Cancer, and Hysterectomy.

Dr. Mary Wilkinson is a medical oncologist caring for patients with breast cancer and gyn malignancies. Dr. Wilkinson sees patients primarily at Sibley Memorial Hospital in Washington DC. She also serves as clinical director of the Under Armour Breast Health Innovation Center at the Sidney Kimmel Comprehensive Cancer Center. Dr. Wilkinson received her undergraduate degree in electrical engineering from Rice University and earned her M.D. from Stanford University School of Medicine. She completed her residency and performed a fellowship in hematology and oncology at the University of California, San Francisco. Dr. Wilkinson joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Wilkinson was director of breast cancer research at the Inova Schar Cancer Institute and president of Medical Oncology Hematology Associates of Northern Virginia. She also spent time on the faculty at Georgetown University and the University of California, San Francisco. Dr. Wilkinson is a member of the American Society of Clinical Oncology. Dr. Wilkinson is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer.

Edward Tanner, M.D., is a professor of gynecologic oncology in the Johns Hopkins Medicine Department of Gynecology and Obstetrics and the medical director for women’s health in the Johns Hopkins National Capital Region. Dr. Tanner is an internationally recognized expert in gynecologic surgery and is known for his surgical skills, compassionate bedside manner, leadership and teaching abilities. Dr. Tanner’s clinical interests include surgical management of advanced gynecologic cancers, including radical debulking surgery for ovarian cancer, as well as minimally invasive surgery for early-stage female cancers. He is particularly focused on developing innovative techniques that reduce complications and speed recovery time. His research interests include sentinel lymph node mapping in endometrial and cervical cancers, exploring ways to reduce complications for patients having surgery for advanced ovarian cancer, robotic single-site surgery and identifying new treatments for patients with uterine sarcoma. He has authored more than 80 articles in peer-reviewed medical journals and has lectured nationally and internationally on sentinel lymph node techniques, uterine sarcoma and surgical innovations for gynecologic cancer. He is the chapter author of “Surgery for Endometrial Cancer” in Telinde’s Operative Gynecology, the definitive textbook for gynecologic surgery techniques in the United States. Dr. Tanner is a member of the NRG Corpus Committee, which develops clinical trials for uterine cancer on behalf of the National Cancer Institute. A Maryland native, Dr. Tanner received his medical degree from the University of Alabama at Birmingham before returning to Baltimore to complete his residency in gynecology and obstetrics at The Johns Hopkins Hospital. He completed a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center, where he was among the first fellows to complete an extensive training program in robotic surgery for gynecologic cancers. Dr. Tanner has served as a faculty member at The Johns Hopkins Hospital as well as the Marcia Stenn Professor and chief of gynecologic oncology at Northwestern University in Chicago. Having served as the gynecologic oncology fellowship program director at both The Johns Hopkins Hospital and Northwestern Memorial Hospital, Dr. Tanner taught the next generation of gynecologic surgeons and health care leaders. Dr. Tanner is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy.

Ebony Hoskins is a Gynecologic Oncologist and an Oncologist in Washington, Washington, D.c.. Dr. Hoskins is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Oophorectomy, and Bladder Reconstruction. Dr. Hoskins is currently accepting new patients.

Willard Barnes is a Gynecologic Oncologist in Washington, Washington, D.c.. Dr. Barnes is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Cancer, Testicular Yolk Sac Tumor, and Oophorectomy.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Dr. Staples sees patients Monday thru Friday in Building D, Level 4. Dr. Jeanine Staples is a fellowship-trained gynecologic oncologist with the Sibley Center for Gynecologic Oncology and Advanced Pelvic Surgery. She is trained in advanced laparoscopic and robotic surgical techniques. She has a special interest in the surgical management of gynecologic malignancies and preinvasive diseases of the vulva, vagina and cervix in addition to complex benign gynecologic diseases. She holds a masters degree in public health and her areas of research interest include screening and prevention of gynecologic malignancies as well as disparities in outcomes of women with gynecologic cancers. Dr. Staples is passionate about reducing disparities in gynecologic cancers through community engagement and education. Dr. Staples has given national presentations and lectures on these topics and is published in the field. She is also passionate about HPV vaccination and serves as a member of the Cancer Action Coalition of Virginia's HPV Taskforce Committee. Videos The Importance of Good Gynecologic Health Selected Publications Staples JN, Duska L. Cancer Screening and Prevention Highlights in Gynecologic Cancer. Obstet Gynecol Clin North Am 2019 Mar;46(1):19-36. PMID: 30683264 Staples JN, Lester J, Li A, Walsh C, Cass I, Karlan BY, Bresee C, Rimel BJ. Language as a barrier to cancer clinical trial accrual: assessing consenting team knowledge and practices for cancer clinical trial consent among low English fluency patients. Applied Cancer Research 2018; 38:14 Staples JN, Peres LC, Camacho TF, Alberg AJ, Bandera EV, Barnoltz-Sloan J, Bondy ML, Crote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Schildkraut JM. Cardiovascular co-morbidities and risk of ovarian carcinoma among African-American women in the African American Cancer Epidemiology Study (AACES). Gynecologic Oncology 2020 Jul; 158: 123-129. PMID: 32362566 Staples JN, Wong MS, Rimel BJ. An Educational Intervention to Improve HPV and Cervical Cancer Knowledge Among African American College Students. Gynecologic Oncology 2018; 149(1):101-105. PMID: 29605043 Patel S, Staples JN, Garcia C, Chatfield L, Ferriss JS, Duska LR. Are minority women less likely to participate in clinical trials? Gynecologic Oncology 2020 May; 157(2):323-328. PMID: 32253046 Lectures & Presentations Racial disparities in surgical outcomes of patients undergoing debulking surgery for ovarian cancer, Oral Presentation, Grand Rounds, University of Virginia Department of Obstetrics and Gynecology, Charlottesville, VA, 6/3/20. Dr. Staples is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Neonatal Ovarian Cyst, Ovarian Cysts, Endometrial Cancer, Ovarian Carcinosarcoma, and Hysterectomy.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Arjun Sood is a Hematologist Oncology specialist and a Hematologist in Alexandria, Virginia. Dr. Sood is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Pleuropulmonary Blastoma. Dr. Sood is currently accepting new patients.

Patricia Rizzo is an Oncologist and a Hematologist in Alexandria, Virginia. Dr. Rizzo is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Breast Cancer in Men, and Inflammatory Breast Cancer. Dr. Rizzo is currently accepting new patients.

Ivan Aksentijevich is a Hematologist Oncology specialist and a Hematologist in Alexandria, Virginia. Dr. Aksentijevich is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Multiple Myeloma. Dr. Aksentijevich is currently accepting new patients.

Mary Cutting is an Obstetrics and Gynecologist in Alexandria, Virginia. Dr. Cutting is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Human Papillomavirus Infection, Pelvic Inflammatory Disease, Vulvovaginitis, Angiomyoma, and Intrauterine Device Insertion. Dr. Cutting is currently accepting new patients.

Yoomi Lee is an Oncologist and a Hematologist in Alexandria, Virginia. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Familial Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Myelodysplastic Syndrome (MDS). Dr. Lee is currently accepting new patients.

Joyce Hamba is a Nurse Practitioner in Washington, Washington, D.c.. Ms. Hamba is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, and Endometrial Cancer.

Kelly Killian is a Nurse Practitioner specialist and a Gynecologic Oncologist in Arlington, Virginia. Ms. Killian is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Malignant Mixed Mullerian Tumor, Ovarian Cancer, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma. Ms. Killian is currently accepting new patients.

Mark Doherty is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Arlington, Virginia. Dr. Doherty is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Endometrial Cancer, and Ovarian Cancer.

Deepnarayan Tiwarri is a Hematologist Oncology specialist and a Hematologist in Clinton, Maryland. Dr. Tiwarri is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Pulmonary Embolism, and Anemia. Dr. Tiwarri is currently accepting new patients.

Sarah Temkin is a Gynecologic Oncologist and an Oncologist in Washington, Washington, D.c.. Dr. Temkin is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Hysterectomy, and Oophorectomy.

Charlotte Gamble is a Gynecologic Oncologist and an Oncologist in Clinton, Maryland. Dr. Gamble is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy.